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Does The Mediterranean Diet or Botanicals Influence Alzheimer’s 
Disease?
Hannah Jester and Antoine Al-Achi*
Campbell University College of Pharmacy & Health Sciences, P.O. Box 1090, Buies Creek, NC 27506, USA
Dementia is a condition that currently affects over 46 million 
people worldwide [1]. It is a growing problem of epidemic proportions 
and while efforts are being made to treat it, the prevalence is estimated 
to affect over 131 million by the year 2050 [1]. Alzheimer’s disease (AD) 
is the most common form of dementia seen today, comprising 60-70% 
of all diagnosed cases of dementia [2]. The purpose of this editorial is 
to review the potential benefits of the Mediterranean diet and some 
botanicals on AD.
Alzheimer’s is characterized by severe cognitive impairment, 
affecting many vital functions such as memory, reasoning and 
judgment, language, learning capacity, and comprehension [2]. 
Alzheimer’s usually affects elderly people over the age of 65, though 
some rare forms have been found to affect individuals under the age of 
40 [2]. In the first or second year of the disease, patients often become 
forgetful and lose some short-term memory, have mild difficulty 
communicating, become lost in familiar surroundings, as well as some 
difficulty reasoning and making decisions [2]. Some patients also 
experience a slight change in mood or behavior [2]. When compared 
to other chronic diseases, patients with Alzheimer’s or other forms of 
dementia often require a higher degree of care [1]. 
Anatomy of Alzheimer’s Disease
The most common, and main hallmark of the disease, is the 
aggregates of β-amyloid protein [3]. The β-amyloid protein itself is 
thought to be toxic to the brain and cause cell death [4]. The toxic form 
of the protein begins as the Amyloid precursor protein (APP), which 
is then cleaved by the enzyme β-secretase [5]. Then, the product of the 
cleavage is cleaved again by γ-secretase, which is thought to produce 
the toxic Aβ42 byproduct [5]. The Aβ42 byproduct is insoluble and 
generally forms the senile plaques [5]. The main mechanism of 
β-amyloid cytotoxicity is believed to be that the plaques destabilize 
calcium homeostasis in the brain by causing an influx of calcium ions 
and via interference with the synaptic transmission of acetylcholine. 
It also causes inflammation in the brain leading to the production of 
reactive oxygen species [4]. The reactive oxygen species then cause 
oxidative stress, damaging mitochondria, also a cause of cell death [4].
Another major hallmark of AD is the so-called Tau neurofibrillary 
tangles, which form inside the neurons. Tau is a protein commonly 
found in microtubules and plays a major role in a cell’s structure [5]. 
The tau protein can undergo a process of hyperphosphorylation, which 
causes the tau to be released from the microtubules where it then 
aggregates into tangles. This both destabilizes neuronal structure as 
well as inhibits the transmission of neurotransmitters like acetylcholine 
[3,5]. 
The Mediterranean Diet
Out of the numerous potential risk factors for Alzheimer’s disease, 
the diet is one of the most prevalent. The Mediterranean diet is thought 
to be associated with a decreased risk for several chronic diseases 
such as cardiovascular disease and cancer [6]. While many studies 
on the subject have been conducted, it is yet unclear what definitive 
effect a Mediterranean diet might have on cognitive function [7,8]. A 
Mediterranean diet is largely characterized by a high intake of vegetables, 
fruit, legumes, cereals, monounsaturated fats accompanied with a low 
intake of saturated fats, and fish. It also includes a relatively low intake 
of meat and dairy products and a moderate intake of wine with meals. 
When broken down into individual parts, a Mediterranean diet offers 
numerous health benefits, such as omega-3 from fish, antioxidants 
from fruits and vegetables, vitamin B12, and monounsaturated fatty 
acids like olive oil [8]. The antioxidants in particular are a current area 
of study for the reduction or prevention of cognitive decline. A possible 
insight into why this type of holistic diet may be more protective than 
any one aspect alone, is that many of the complex food combinations 
are likely synergistic in nature when it comes to health benefits [9,10].
In several studies, the Mediterranean diet was found to have a 
positive effect on cognitive decline and the incidence of AD. In large, 
non-Mediterranean populations over several years, a general decrease 
in the risk or incidence of AD was associated with a higher adherence 
to a Mediterranean diet [7,8]. However, in other studies, even high 
adherence did not result in significant changes in cognitive decline [8]. 
It is hypothesized that while a Mediterranean diet may have a positive 
or even preventative effect on the incidence of AD, the benefits decrease 
with onset of the disease and produce little to no effect on late stage 
AD [8]. One study conducted on a French population observed an 
overall decline in annual cognitive dysfunction with higher adherence 
to the diet but saw no other significant improvements [8]. The same 
study suggests that a Mediterranean diet may only be cognitively 
beneficial prior to five years preceding the diagnosis of AD [8]. In a 
study analyzing the effect of a Mediterranean diet on both AD and mild 
cognitive impairment, it was found that a higher adherence to the diet 
resulted in a significantly decreased risk for both [7]. However, there 
was no significant difference between mild cognitive impairment and 
AD [7]. This suggests that a Mediterranean diet may have a general 
protective effect on cognitive function but may not be specifically 
beneficial to AD patients. It should also be noted that the study was 
performed on an isolated Australian population and achieved much 
the same results as previous studies performed in the US and France 
[7]. Despite the growing evidence for a correlation between a high 
adherence to a Mediterranean diet and a decreased risk of AD, other 
results are unclear and inconclusive [11]. This has led to the possibility 
that the diet may not be an effective tool against AD or that there may 
be other factors at work.
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apoptotic proteins and affect amyloid precursor protein metabolism 
[25]. It is a potent and reversible acetylcholinesterase inhibitor [24,26]. 
Currently, Huperzine A has been approved as a memory enhancing 
dietary supplement [26]. In a clinical setting, it has been shown to 
improve cognition with few side effects [27]. It should be noted that 
one study found Huperzine A to be more potent than both donepezil 
and rivastigmine (drugs for AD) in increasing acetylcholine levels 
in the brain and had a longer lasting effect [28]. While Huperzine A 
appears promising, it has mostly only been tested in China and more 
studies are needed to determine its effect on Alzheimer’s patients.
Rosemary
The herb was commonly used by the Greek and Roman civilizations 
as a memory enhancer [29]. It is most commonly known for its 
antioxidant activity, as it has over two dozen different antioxidant 
constituents, most notable rosmarinic acid [24]. It is a modest 
acetylcholinesterase inhibitor with an activity below that of both sage 
and lemon balm [30]. Rosemary has been found to increase alertness, 
reduce anxiety, and improve cognitive function [31,32]. 
Sage
It is an herb commonly used in Europe to enhance memory and 
cognition [22]. It has antioxidant activity, mainly from carnosic and 
rosmarinic acid which help protect against oxidative damage [24]. Sage 
has anti-inflammatory constituents and acts as an acetylcholinesterase 
inhibitor [33-35]. Sage extracts have been found to improve cognition 
both in healthy young adults and in patients with mild to moderate 
Alzheimer’s [36-40]. It also has anti-butyrylcholinesterase activity, 
making it doubly active [41,22]. One study found that sage reduced 
the amyloid burden in vivo and had a neuro-protective effect against 
amyloid cytotoxicity due to rosmarinic acid [42]. 
Turmeric
This Indian spice has anti-oxidant activity [24]. The active 
ingredient in Turmeric is curcumin which also has anti-inflammatory 
activity [43]. One study found that it even reduced the amyloid 
burden in transgenic mice [43]. Another study suggested that there 
is epidemiological evidence that turmeric-filled diet is associated with 
improved cognitive performance as well as a lower prevalence of AD 
[44,22]. Curcumin was also found to prevent the oligomerization and 
aggregation of β-amyloid in a mice model [45]. 
Lemon balm
Melissa officinalis, more commonly known as lemon balm, has 
been used throughout Europe for centuries for its anti-depressant 
properties and memory enhancing capabilities [22]. It is a weak 
acetylcholinesterase inhibitor, largely coming from rosmarinic acid 
[24]. It also has antioxidant properties and has been shown to improve 
cognition in a clinical setting [24]. Melissa extracts have the capability 
to bind to nicotinic, muscarinic, and GABAA receptors [46,47]. In a 
clinical setting, lemon balm extracts were found to reduce cognitive 
impairment in patients with Alzheimer’s [29]. 
In conclusion, AD is a growing problem globally. The Mediterranean 
diet and herbal remedies could play a role in controlling this disease. 
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